Development and Manufacturing Agreement and Master Service Agreement (Details) - USD ($) $ in Thousands |
1 Months Ended | 3 Months Ended | |||
|---|---|---|---|---|---|
Sep. 30, 2021 |
Sep. 30, 2020 |
Mar. 31, 2026 |
Mar. 31, 2025 |
Dec. 31, 2025 |
|
| Temporary Equity [Line Items] | |||||
| Research and development expense | $ 20,925 | $ 11,447 | |||
| Prepaid research and development | 3,260 | $ 5,609 | |||
| Collaborative Arrangement | |||||
| Temporary Equity [Line Items] | |||||
| Master Service Agreement, automatic renewal term | 1 year | ||||
| Master Service Agreement, cancellation notice period | 90 days | ||||
| Research and development expense | 10,500 | $ 8,600 | |||
| Prepaid research and development | $ 1,900 | $ 4,100 | |||
| Convertible notes payable | Collaborative Arrangement | |||||
| Temporary Equity [Line Items] | |||||
| Notes face amount | $ 500 | ||||
| Series A-2 preferred stock | Convertible notes payable | Collaborative Arrangement | |||||
| Temporary Equity [Line Items] | |||||
| Stock issued for debt conversion (in shares) | 238,008 | ||||
| X | ||||||||||
- Definition Collaborative Arrangement, Automatic Renewal Term No definition available.
|
| X | ||||||||||
- Definition Collaborative Arrangement, Cancellation Notice Period No definition available.
|
| X | ||||||||||
- Definition Prepaid Research And Development, Current No definition available.
|
| X | ||||||||||
- Definition The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Face (par) amount of debt instrument at time of issuance. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|